← All companies
HURA
TuHURA Biosciences, Inc.
$2.14
-0.03 -1.38%
Key statistics
from XBRL data in SEC filingsMarket cap
$136M
Revenue (TTM)
$0.00
Net income (TTM)
-$31.9M
EPS (TTM)
$-0.61
P/E ratio
—
Dividend yield
—
Free cash flow
-$27.7M
Cash
$6.30M
Total assets
$29.7M
Gross margin
—
52-week range
$0.41 – $3.90
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Took on a direct financial obligation
Jul 29, 2026
8-K
Took on a direct financial obligation
Jul 7, 2026
8-K
Item 5.08
Jun 17, 2026
8-K
Took on a direct financial obligation
May 29, 2026
10-Q
Quarter ended 2026-03-31
May 15, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
May 15, 2026
8-K/A
Other events
Apr 30, 2026
10-K/A
Fiscal year ended 2025-12-31
Apr 30, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure
Apr 22, 2026
8-K
Director or officer change; Other events
Apr 8, 2026
8-K
Results of operations (earnings release)
Apr 1, 2026
10-K
Fiscal year ended 2025-12-31
Mar 31, 2026
8-K
Delisting notice or listing-rule failure
Jan 30, 2026
8-K
Entered a material agreement; Other events
Dec 10, 2025
8-K
Entered a material agreement; Took on a direct financial obligation
Dec 5, 2025
8-K
Regulation FD disclosure
Nov 25, 2025
8-K
Other events
Nov 18, 2025
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
8-K
Results of operations (earnings release)
Nov 14, 2025
8-K
Entered a material agreement
Nov 4, 2025
8-K
Other events
Nov 3, 2025
8-K
Entered a material agreement; Took on a direct financial obligation
Oct 31, 2025
8-K
Entered a material agreement
Sep 11, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Results of operations (earnings release)
Aug 14, 2025
8-K/A
Aug 12, 2025
8-K
Completed an acquisition or disposition; Regulation FD disclosure
Jun 30, 2025
8-K
Amended charter or bylaws
Jun 27, 2025
8-K
Shareholder vote results; Regulation FD disclosure
Jun 24, 2025
8-K
Jun 12, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure
Jun 6, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
8-K
Results of operations (earnings release)
May 15, 2025
8-K/A
Director or officer change
May 7, 2025
8-K
Entered a material agreement; Director or officer change
May 7, 2025
8-K
Results of operations (earnings release)
Apr 1, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025
8-K
Regulation FD disclosure
Mar 18, 2025
8-K
Director or officer change; Regulation FD disclosure
Mar 12, 2025
8-K
Entered a material agreement
Feb 14, 2025